Chimin Health Management Co

Chimin Health Management Co ROE

The Return on Equity (ROE) of Chimin Health Management Co (603222.SS) as of Nov 2, 2026 is -20.14 %. In the previous year, Return on Equity (ROE) was -4.03 % — a change of 399.44% (lower).

ROE

-20.14 %

YoY

399.44%

Last updated:

In 2025, Chimin Health Management Co's return on equity (ROE) was -20.14 %, a 399.44% increase from the -4.03 % ROE in the previous year.

The Chimin Health Management Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
3.96 CNY
Jan 1, 2019
7.93 CNY
Jan 1, 2020
0.74 CNY
Jan 1, 2021
11.91 CNY
Jan 1, 2022
2.02 CNY
Jan 1, 2023
-4.15 CNY
Jan 1, 2024
-4.03 CNY
Jan 1, 2025
-20.14 CNY
The Chimin Health Management Co ROE history
YEARROEYoY
-20.14 %+399.44%
-4.03 %-2.95%
-4.15 %-305.83%
2.02 %-83.05%
11.91 %+1,510.19%
0.74 %-90.68%
7.93 %+100.39%
3.96 %-40.59%
6.67 %+22.44%
5.44 %-24.15%
7.18 %-44.97%
13.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Chimin Health Management Co Stock analysis

What does Chimin Health Management Co do? Chimin Health Management Co., Ltd. generates revenue through the manufacturing and sale of pharmaceutical products, primarily focusing on Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, and injection and puncture machinery such as safety syringes, sterile syringes, and infusion sets. The company serves domestic and overseas markets, with its products distributed across these regions. Its core business involves producing medical devices and pharmaceutical packaging solutions for healthcare providers and distributors. The firm's product portfolio includes Non Polyvinyl chloride (PVC) soft bag infusion products, plastic bottle infusion products, and injection and puncture machinery products, which are sold to healthcare institutions and distributors within China and internationally. These products are essential for medical procedures requiring sterile fluid delivery and safe injection practices. Chimin Health Management's domestic market presence is complemented by its international distribution channels. Chimin Health Management Co., Ltd. operates with a workforce of 1,851 full-time employees, supporting its manufacturing and sales operations. The company's revenue streams are derived from the direct sale of its pharmaceutical and medical device products to healthcare providers and distributors, both within China and abroad. Its focus on Non Polyvinyl chloride (PVC) soft bag infusion products and related medical equipment positions it as a key supplier in the healthcare sector. Chimin Health Management Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Chimin Health Management Co's Return on Equity (ROE)

Chimin Health Management Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Chimin Health Management Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Chimin Health Management Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Chimin Health Management Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Chimin Health Management Co stock

Return on Equity (ROE) of Chimin Health Management Co is -20.14 % in 2025.

Return on Equity (ROE) of Chimin Health Management Co changed from -4.03 % to -20.14 %, representing a 399.44% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Chimin Health Management Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Chimin Health Management Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Chimin Health Management Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Chimin Health Management Co